Xencor director sells 7,527 shares in planned trade

Xencor Inc director Kevin Charles Gorman reported an open-market sale of 7,527 shares of Xencor common stock.

(Neutral)

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Xencor Inc director Kevin Charles Gorman reported an open-market sale of 7,527 shares of Xencor common stock. The shares were sold at an average price of $12.31 per share. This trade was executed under a 10b5-1 trading plan adopted on June 27, 2025. Following the sale, Gorman directly holds 11,378 Xencor shares.

Insider Trade Summary 10b5-1

Net Seller: 7,527 shares

Net Sell 1 txn

Insider GORMAN KEVIN CHARLES

Role Director

Sold 7,527 shs ($93K)

Type	Security	Shares	Price	Value
Sale	Common Stock	7,527	$12.31	$93K

Holdings After Transaction: Common Stock — 11,378 shares (Direct)

Footnotes (1)

F1. This transaction is pursuant to a 10b5-1 plan adopted by the Reporting Person on June 27, 2025.

Key Figures

Shares sold: 7,527 shares Sale price: $12.31 per share Shares held after sale: 11,378 shares

3 metrics

Shares sold 7,527 shares Open-market sale of Xencor common stock

Sale price $12.31 per share Average price for the 7,527 shares sold

Shares held after sale 11,378 shares Direct ownership following the reported transaction

Key Terms

10b5-1 plan, open-market sale, Common Stock

3 terms

10b5-1 plan financial

"This transaction is pursuant to a 10b5-1 plan adopted by the Reporting Person on June 27, 2025."

A 10b5-1 plan is a pre-arranged strategy that allows company insiders to buy or sell their shares at predetermined times and prices, even while they are aware of confidential information. It acts like a scheduled appointment for trading, helping ensure transactions happen transparently and legally, which can reassure investors that trades are not based on insider knowledge.

open-market sale financial

"transaction_action: open-market sale"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Common Stock financial

"security_title: Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Xencor (XNCR) director Kevin Gorman report?

Xencor director Kevin Charles Gorman reported selling 7,527 shares of common stock. The transaction was an open-market sale at an average price of $12.31 per share, and it was carried out under a pre-arranged 10b5-1 trading plan.

At what price did XNCR director Kevin Gorman sell his Xencor shares?

Kevin Charles Gorman sold his 7,527 Xencor common shares at an average price of $12.31 per share. This reflects an open-market sale, executed pursuant to an established 10b5-1 trading plan adopted before the transaction date.

How many Xencor (XNCR) shares does Kevin Gorman hold after the reported sale?

After selling 7,527 shares, Kevin Charles Gorman directly holds 11,378 Xencor common shares. These post-transaction holdings reflect his remaining direct ownership position reported in the filing following the single disclosed open-market sale.

Was the Xencor (XNCR) insider sale made under a Rule 10b5-1 trading plan?

Yes. The filing notes the transaction was made pursuant to a 10b5-1 trading plan adopted by Kevin Charles Gorman on June 27, 2025. Such plans pre-schedule trades, reducing the significance of trade timing as a signal of insider sentiment.

What type of security did XNCR director Kevin Gorman sell in this Form 4?

Kevin Charles Gorman sold Xencor common stock in this reported transaction. The Form 4 shows a single open-market sale of 7,527 common shares at $12.31 per share, leaving him with 11,378 common shares held directly afterward.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/17/2026 - 04:02 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GORMAN KEVIN CHARLES

(Last)

(First)

(Middle)

C/O XENCOR, INC.

465 N HALSTEAD STREET, SUITE 200

(Street)

PASADENA

CALIFORNIA

91107

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Xencor Inc [ XNCR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/15/2026		S⁽¹⁾		7,527	D	$12.31	11,378	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. This transaction is pursuant to a 10b5-1 plan adopted by the Reporting Person on June 27, 2025.

Remarks:

	/s/ Celia E. Eckert, Attorney-in-Fact	06/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR